Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol and Docetaxel in Previously Untreated Advanced Pancreatic Cancer
NCT00238199Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jun 2002
- Primary completion
- Aug 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in pancreatic cancer (PC), sponsored by OHSU Knight Cancer Institute. Started Jun 2002; status: completed.
02
Drugs
calcitriol
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00238199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238199.